Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


24.04.2017

4 AIDS
1 Am J Epidemiol
2 Antimicrob Agents Chemother
1 Antivir Ther
1 BMC Cancer
3 Clin Infect Dis
1 Drugs
7 J Acquir Immune Defic Syndr
4 J Infect Dis
3 J Virol
1 Lancet Gastroenterol Hepatol
5 Lancet HIV
1 Nat Med
2 Pediatr Infect Dis J
1 PLoS Med
14 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. GIBELLINI L, Pecorini S, de Biasi S, Bianchini E, et al
    HIV-DNA content in different CD4+ T cell subsets correlates with CD4: CD8 ratio or length of efficient treatment.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001510.
    PubMed     Text format     Abstract available

  2. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511.
    PubMed     Text format     Abstract available

  3. SCHAEFER R, Gregson S, Eaton JW, Mugurungi O, et al
    Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from a general-population cohort in Zimbabwe.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001506.
    PubMed     Text format     Abstract available

  4. BREGIGEON S, Galinier A, Zaegel-Faucher O, Cano CE, et al
    Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001507.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  5. TODD JV, Cole SR, Pence BW, Lesko CR, et al
    Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women.
    Am J Epidemiol. 2017 Apr 18:1-10. doi: 10.1093.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  6. ZHAO C, Gunawardana M, Villinger F, Baum MM, et al
    Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.02465.
    PubMed     Text format     Abstract available

  7. NAKAMURA RL, Burlingame MA, Yang S, Crosby DC, et al
    Identification and optimization of thienopyridine carboxamides as inhibitors of HIV regulatory complexes.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.02366.
    PubMed     Text format     Abstract available


    Antivir Ther

  8. LUBEL J, Strasser S, Stuart KA, Dore G, et al
    Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir +/- ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.
    Antivir Ther. 2017 Apr 19. doi: 10.3851/IMP3168.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. CHIU CG, Smith D, Salters KA, Zhang W, et al
    Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
    BMC Cancer. 2017;17:270.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  10. CHOW EPF, Callander D, Fairley CK, Zhang L, et al
    Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Switching to efavirenz versus remaining on ritonavir-boosted lopinavir in HIV-infected children exposed to nevirapine: long-term outcomes of a randomized trial.
    Clin Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. EATON EF, Gravett RM, Tamhane AR, Mugavero MJ, et al
    Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
    Clin Infect Dis. 2017 Apr 15. doi: 10.1093.
    PubMed     Text format     Abstract available


    Drugs

  13. AL-SALAMA ZT, Deeks ED
    Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4.
    Drugs. 2017 Apr 17. doi: 10.1007/s40265-017-0739.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  14. CASETTI R, Pinnetti C, Sacchi A, De Simone G, et al
    HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001392.
    PubMed     Text format     Abstract available

  15. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of antiretroviral treatment containing tenofovir difumarate on the telomere length of aviremic HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001391.
    PubMed     Text format     Abstract available

  16. GUERRI-FERNANDEZ R, Molina-Morant D, Villar-Garcia J, Herrera S, et al
    Bone density, microarchitecture and tissue quality following long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001396.
    PubMed     Text format     Abstract available

  17. RIDOLFO AL, Oreni L, Vassalini P, Resnati C, et al
    Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan Italy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001388.
    PubMed     Text format     Abstract available

  18. ROSENBERG NE, Graybill LA, Wesevich A, McGrath N, et al
    The Impact of Couple HIV Testing and Counseling on Consistent Condom Use among Pregnant Women and their Male Partners: An Observational Study.
    J Acquir Immune Defic Syndr. 2017 Apr 18. doi: 10.1097/QAI.0000000000001398.
    PubMed     Text format     Abstract available

  19. MALLAMPATI D, Ford N, Hanaford A, Sugandhi N, et al
    Performance of virological testing for early infant diagnosis: A systematic review.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001387.
    PubMed     Text format     Abstract available

  20. GAIST P, Stirratt MJ
    The Roles of Behavioral and Social Science Research in the Fight against HIV/AIDS: A Functional Framework.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001399.
    PubMed     Text format     Abstract available


    J Infect Dis

  21. GAY CL, Bosch RJ, Ritz J, Hataye JM, et al
    Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. VAN LAARHOVEN A, Dian S, Ruesen C, Hayati E, et al
    Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. CHOI JY, Pond SLK, Anderson CM, Richman DD, et al
    Molecular Features of the V1-V4 Coding Region of Sexually Transmitted HIV-1.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  25. MILLER CM, Akiyama H, Agosto LM, Emery A, et al
    Virion associated Vpr alleviates a post-integration block to HIV-1 infection of dendritic cells.
    J Virol. 2017 Apr 19. pii: JVI.00051-17. doi: 10.1128/JVI.00051.
    PubMed     Text format     Abstract available

  26. DI PILATO M, Mejias-Perez E, Sorzano COS, Esteban M, et al
    Distinct roles of vaccinia virus NF-kB inhibitor proteins A52, B15 and K7 in the immune response.
    J Virol. 2017 Apr 19. pii: JVI.00575-17. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available

  27. KIGUOYA MW, Mann JK, Chopera D, Gounder K, et al
    Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression.
    J Virol. 2017 Apr 19. pii: JVI.00253-17. doi: 10.1128/JVI.00253.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  28. WELZEL TM, Asselah T, Dumas EO, Zeuzem S, et al
    Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial.
    Lancet Gastroenterol Hepatol. 2017 Apr 13. pii: S2468-1253(17)30071.
    PubMed     Text format     Abstract available


    Lancet HIV

  29. TARR PE, Kovari H
    Another statin option in HIV.
    Lancet HIV. 2017 Apr 13. pii: S2352-3018(17)30072.
    PubMed     Text format    

  30. ABERG JA, Sponseller CA, Ward DJ, Kryzhanovski VA, et al
    Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
    Lancet HIV. 2017 Apr 13. pii: S2352-3018(17)30075.
    PubMed     Text format     Abstract available

  31. CANIGLIA EC, Cain LE, Sabin CA, Robins JM, et al
    Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.
    Lancet HIV. 2017 Apr 11. pii: S2352-3018(17)30043.
    PubMed     Text format     Abstract available

  32. MCMAHON J, Crowe SM
    Less frequent CD4 monitoring in virologically suppressed HIV.
    Lancet HIV. 2017 Apr 11. pii: S2352-3018(17)30070.
    PubMed     Text format    

  33. NANDWANI R
    Pre-exposure prophylaxis is approved in Scotland.
    Lancet HIV. 2017 Apr 13. pii: S2352-3018(17)30078.
    PubMed     Text format    


    Nat Med

  34. HONEYCUTT JB, Thayer WO, Baker CE, Ribeiro RM, et al
    HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.
    Nat Med. 2017 Apr 17. doi: 10.1038/nm.4319.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  35. CONTRERAS GA, Murphy JR, Heresi GP
    Plasma Interferon Gamma-Inducible Protein 10 (IP10) Level Associates with Abnormal Memory B Cells Phenotypes in Perinatal HIV Infection.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001612.
    PubMed     Text format     Abstract available

  36. LAPPHRA K, Oungkananukit P, Saihongthong S, Phongsamart W, et al
    Persistence of Hepatitis B Immunity Following 3-Dose Infant Primary Series in HIV-Infected Thai Adolescents and Immunologic Response to Revaccination.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001613.
    PubMed     Text format     Abstract available


    PLoS Med

  37. MCNAIRY ML, Abrams EJ, Rabkin M, El-Sadr WM, et al
    Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.
    PLoS Med. 2017;14:e1002278.
    PubMed     Text format     Abstract available


    PLoS One

  38. FOURCADE G, Germi R, Guerber F, Lupo J, et al
    Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.
    PLoS One. 2017;12:e0175574.
    PubMed     Text format     Abstract available

  39. YEGANEH N, Simon M, Mindry D, Nielsen-Saines K, et al
    Barriers and facilitators for men to attend prenatal care and obtain HIV voluntary counseling and testing in Brazil.
    PLoS One. 2017;12:e0175505.
    PubMed     Text format     Abstract available

  40. SESHADRI C, Sedaghat N, Campo M, Peterson G, et al
    Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0175844.
    PubMed     Text format     Abstract available

  41. MORON-LOPEZ S, Puertas MC, Galvez C, Navarro J, et al
    Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue.
    PLoS One. 2017;12:e0175899.
    PubMed     Text format     Abstract available

  42. CHILIMAMPUNGA C, Lijenje S, Sherman J, Nindi K, et al
    Acceptability and feasibility of early infant male circumcision for HIV prevention in Malawi.
    PLoS One. 2017;12:e0175873.
    PubMed     Text format     Abstract available

  43. MCCARTHY EA, Subramaniam HL, Prust ML, Prescott MR, et al
    Quality improvement intervention to increase adherence to ART prescription policy at HIV treatment clinics in Lusaka, Zambia: A cluster randomized trial.
    PLoS One. 2017;12:e0175534.
    PubMed     Text format     Abstract available

  44. NHAVOTO JA, Gronlund A, Klein GO
    Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers.
    PLoS One. 2017;12:e0176051.
    PubMed     Text format     Abstract available

  45. LU Y, Figler B, Huang H, Tu YC, et al
    Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms.
    PLoS One. 2017;12:e0173548.
    PubMed     Text format     Abstract available

  46. CAVALCANTI DD, Alves LV, Furtado GJ, Santos CC, et al
    Echocardiographic findings in infants with presumed congenital Zika syndrome: Retrospective case series study.
    PLoS One. 2017;12:e0175065.
    PubMed     Text format     Abstract available


  47. Correction: Risk factors associated with sexually transmitted infections among HIV infected men who have sex with men.
    PLoS One. 2017;12:e0176579.
    PubMed     Text format     Abstract available

  48. TAIEB F, Madec Y, Cournil A, Delaporte E, et al
    Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.
    PLoS One. 2017;12:e0174767.
    PubMed     Text format     Abstract available

  49. RIBEIRO SP, Milush JM, Cunha-Neto E, Kallas EG, et al
    Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection.
    PLoS One. 2017;12:e0176509.
    PubMed     Text format     Abstract available

  50. GAFOS M, Brodnicki E, Desai M, McCormack S, et al
    Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study.
    PLoS One. 2017;12:e0175596.
    PubMed     Text format     Abstract available

  51. VOLPINI LPB, Boldrini NAT, de Freitas LB, Miranda AE, et al
    The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results.
    PLoS One. 2017;12:e0176422.
    PubMed     Text format     Abstract available


    PLoS Pathog

  52. GANDHI RT, McMahon DK, Bosch RJ, Lalama CM, et al
    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
    PLoS Pathog. 2017;13:e1006285.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  53. WIEGAND A, Spindler J, Hong FF, Shao W, et al
    Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.
    Proc Natl Acad Sci U S A. 2017 Apr 17. pii: 201617961.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: